Home/Filings/4/0000897423-11-000068
4//SEC Filing

GROUP VI 31 LLC 4

Accession 0000897423-11-000068

CIK 0001472595other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 5:30 PM ET

Size

9.0 KB

Accession

0000897423-11-000068

Insider Transaction Report

Form 4
Period: 2011-03-30
Transactions
  • Sale

    Common Stock

    2011-03-30$22.44/sh814,110$18,268,62814,036,172 total
Transactions
  • Sale

    Common Stock

    2011-03-30$22.44/sh814,110$18,268,62814,036,172 total
Transactions
  • Sale

    Common Stock

    2011-03-30$22.44/sh814,110$18,268,62814,036,172 total
Footnotes (2)
  • [F1]In connection with the registered offering of common stock, par value $0.01 per share (the "Common Stock") of Accretive Health, Inc. by certain selling stockholders pursuant to an underwriting agreement (the "Underwriting Agreement") dated March 24, 2011, FW Oak Hill Accretive Investors, L.P. (the "Oak Hill Partnership"), as a selling stockholder, sold 707,922 shares of Common Stock. Pursuant to the Underwriting Agreement, the underwriters exercised their election to purchase additional shares of Common Stock from the selling stockholders. The Oak Hill Partnership sold an additional 106,188 shares of Common Stock in connection with the underwriters' exercise of the election to purchase additional shares. The registered offering closed on March 30, 2011.
  • [F2]Group VI 31, LLC ("Group VI 31") is the sole general partner of the Oak Hill Partnership, which is the direct holder of the shares reported herein. J. Taylor Crandall ("Crandall") is the sole member and President of Group VI 31 and a limited partner of the Oak Hill Partnership. Crandall and Group VI 31 disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

Issuer

Accretive Health, Inc.

CIK 0001472595

Entity typeother

Related Parties

1
  • filerCIK 0001247520

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:30 PM ET
Size
9.0 KB